地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18327026838
传真:18327026838
邮箱:sales@amyjet.com
<艾美捷科技代理Helvetica Health Care品牌全系列产品
Helvetica Health Care是一家位于瑞士日内瓦的医疗保健公司,致力于通过创新的产品和技术来管理健康和提高生活质量。作为瑞士生物技术协会的成员,Helvetica Health Care通过了ISO 13485认证,在质量和创新方面坚持最高标准。涵盖各种质量控制和验证面板,适用于不同的分子测试平台和检测。这些产品有多种规格,可用于单一或多种分析物的检测,帮助实验室监控测试性能,确保测试的准确性和可靠性。其质量控制和验证组合可根据产品配置、填充量和分析物浓度进行定制,满足不同平台的需求。
▎Helvetica Health Care产品线
Helvetica Health Care公司的产品涵盖:抗体、生命科学产品、血液分离产品、临床/诊断样本、质控品与标准品、分子生物学产品、细胞因子与生长因子、ELISA试剂盒/Western印迹相关产品、微生物、氧化应激产品、诊断产品以及人血浆制品。

▎Helvetica Health Care部分产品列表
| 货号 | 产品描述 |
| NATFRC-6C | NATtrol Flu/RSV/SARS-CoV-2 Positive Control (6 x 0.5mL) |
| NATCV9-6C | NATtrol Flu/RSV/SARS-CoV-2 Negative Control (6 x 0.5mL) |
| NATRPC2.1-BIO | NATtrol Respiratory Panel 2.1 (RP2.1) Controls (12 x 0.3mL) |
| NATRVP2.1-BIO | NATtrol Respiratory Verification Panel 2.1 (24 x 0.6mL) (EA) |
| NATRVP2.1-BIO Plus | NATtrol Respiratory Verification Panel 2 Plus (+NATCOV(MR)-BIO) (24x 0.6 ml + 1x 0.6 ml) |
| NATRVP2-QIA | NATtrol Respiratory Verification Panel 2 (21 x 0.25mL) (EA) |
| NATSARS(COV2)-VP | NATtrol SARS-CoV-2 Variant Panel (4 x 0.5mL) |
| NATSARS(COV2)-ERC | SARS-Related Coronavirus 2 (SARS-CoV-2) External Run Control (6 x 0.5 mL) |
| NATSARS(COV2)-ERC1 | NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Positive Control (6x 1.0 ml) |
| NATSARS(COV2)-NEG | SARS-Related Coronavirus 2 (SARS-CoV-2) Negative Control (6 x 0.5 mL) |
| NATSARS(COV2)-NEG1 | NATtrol SARS-Related Coronavirus 2 (SARS-COV-2) Negative Control (6x 1.0 ml) |
| NATSARS(COV2)-ST | SARS-Related Coronavirus 2 (SARS-CoV-2) Stock |
| NATSARS(COV2-SA)-ST | NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.351 Stock (1mL) |
| NATSARS(COV2-UK)-ST | NATtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Variant B.1.1.7 Stock (1mL) |
| 0810229-0.5mg | Coronavirus 229E Lysate (0.5 mg) |
| 0810587 | SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (1 mg) |
| 0810587-0.5mg | SARS-CoV-2 (Isolate: USA-WA1/2020) Lysate (0.5 mg) |
| 0810587CFHI-0.5mL | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (0.5 mL) |
| 0810587CFHI | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (Heat Inactivated) (1.0 mL) |
| 0810587UV | SARS-CoV-2 (Isolate: USA-WA1/2020) Culture Fluid (UV Inactivated) (1 mL) |
| 0810589CFHI | SARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810589UV | SARS-CoV-2 (Isolate: Italy-INMI1) Culture Fluid (UV Inactivated) (1 mL) |
| 0810590CFHI | SARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810590UV | SARS-CoV-2 (Isolate: Hong Kong/VM20001061/2020) Culture Fluid (UV Inactivated) (1 mL) |
| 0810617UV | SARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) Culture Fluid (UV)) |
| 0810618UV | SARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) Culture Fluid (UV) |
| 0810619UV | SARS-CoV-2 Iso1 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated) |
| 0810620UV | SARS-CoV-2 Iso2 Lin B.1.526_2021 Iota (NY-Wadsworth-21025952-01/2021) CF (UV Inactivated) |
| 0810621UV | SARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) CF (UV Inactivated) |
| 0810622UV | SARS-CoV-2 Lineage B.1.595_2020 (NY-Wadsworth-33126-01/2020) CF (UV Inactivated) |
| 0810612CFHI | SARS-CoV-2 Variant B.1.1.7 (Isolate:USA/CA_CDC_5574/2020) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810612UV | SARS-CoV-2 Lineage B.1.1.7; Alpha Variant (USA/CA_CDC_5574/2020) CF (UV Inactivated) (1 mL) |
| 0810613CFHI | SARS-CoV-2 Variant B.1.351(Isolate:South_Africa/KRISP-K005325/2020) CF (Heat Inactivated) (1 mL) |
| 0810613UV | SARS-CoV-2 Lineage B.1.351; Beta (South_Africa/KRISP-K005325/2020) CF (UV Inactivated) (1 mL) |
| 0810614CFHI | SARS-CoV-2 Variant B.1.1.7 (Isolate:England/204820464/2020) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810614UV | SARS-CoV-2 Lineage B.1.1.7 Alpha Variant (England/204820464/2020) CF (UV Inactivated) (1 mL) |
| 0810616CFHI | SARS-CoV-2 Lineage P1; Gamma Variant (Japan/TY7-503/2021) CF (Heat Inactivated) (1 mL) |
| 0810616UV | SARS-CoV-2 Lineage P1; Gamma Variant (Isolate: Japan/TY7-503/2021) CF (UV Inactivated) (1 mL) |
| 0810617CFHI | SARS-CoV-2 Lineage P1_2021; Gamma Variant (NY-Wadsworth-21033899-01/2021) – CFHI (1.0 ml) |
| 0810618CFHI | SARS-CoV-2 Lineage P2_2021; Zeta Variant (NY-Wadsworth-21006055-01/2021) – CFHI (1.0 ml) |
| 0810619CFHI | SARS-CoV-2 Lso1 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml) |
| 0810620CFHI | SARS-CoV-2 Lso2 Lin B.1.526_2021 Lota (NYWadsworth-21025952-01/2021) – CFHI (1.0 ml) |
| 0810621CFHI | SARS-CoV-2 Lineage B.1_2020 (NY-Wadsworth-103677-01/2020) – CFHI (1.0 ml) |
| 0810622CFHI | SARS-CoV-2 Lineage E3.1.595J2020 (NYWadsworth-33126-01/2020) – CFHI (1.0 ml) |
| 0810623UV | SARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (UV Inactivated) |
| 0810623CFHI | SARS-CoV-2 Lineage B.1.617.1 Kappa Variant (USA/CA-Stanford-15_S02/2021) CF (Heat Inactivated) |
| 0810624UV | SARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (UV Inactivated) |
| 0810624CFHI | SARS-CoV-2 Lineage B.1.617.2; Delta Variant (USA/PHC658/2021) CF (Heat Inactivated) |
| 0820010CFHI | VeroE6 Culture Fluid (Heat Inactivated) (1 mL) |
| 0801043 | Goat Anti-SARS-CoV-2 Polyclonal Serum (0.5 ml) |
| 0831042 | SARS-CoV-2 (recombinant) Stock (1 x 1.0 mL) |
| 0831043 | SARS-CoV-2 (E/ORF1ab recombinant) Stock (1 x1.0mL) |
| NATSARS-ST | Coronavirus SARS Stock (Qualitative) (1 mL) |
| NATCOV(229E)-ST | Coronavirus 229E Stock (Qualitative) (1 mL) |
| 0810229CFHI | Coronavirus (Strain: 229E) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810229 | Coronavirus Strain: 229E Lysate |
| 0810229UV | Coronavirus (Strain: 229E) Culture Fluid (UV Inactivated) (1 mL) |
| NATCOV(NL63)-ST | Coronavirus NL63 Stock (Qualitative) (1 mL) |
| 0810228CFHI | Coronavirus (Strain: NL63) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810228 | Coronavirus Strain: NL63 Lysate |
| 0810228UV | Coronavirus (Strain: NL63) Culture Fluid (UV Inactivated) (1 mL) |
| NATCOV(OC43)-ST | Coronavirus OC43 Stock (Qualitative) (1 mL) |
| 0810024CFHI | Coronavirus (Strain: OC43) Culture Fluid (Heat Inactivated) (1 mL) |
| 0810024 | Coronavirus Strain: OC43 Lysate |
| NATMERS-ST | MERS-CoV Stock (Qualitative) (1 mL) |
| NATMR-BIO | NATtrol MERS Recombinant Pack (2x 0.2 ml +0.5 ml) |
| NATCOV(MR)-BIO | NATtrol MERS-S. Cerevisiae (0.6 ml) |
| 0810575 | MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(1mg) |
| 0810575-0.5mg | MERS-COV (Strain: Florida/USA-2_Saudi Arabia_2014) Lysate(0.5mg) |
| CV033122 | COVID-19 Cross Over Panel (40x 1.0 ml) |
<艾美捷科技代理Cypex品牌全系列产品
BioIVT作为生命科学和诊断行业的领军企业,专注于提供健康对照与疾病状态样本,包括人和动物的组织或制品、ADME-Tox产品及研究服务、细胞与基因治疗产品、血液及其他生物流体。凭借其在控制和疾病状态样本领域的专注与深耕,BioIVT助力全球科研工作者实现更智能的科学研究,加速医学突破的步伐。

▍Cypex产品线
● 生物体液(血液来源):提供用于生物标志物发现和临床前研究的人和动物全血、血浆、血清及其他血液来源的生物样本。涵盖骨髓、巴菲大衣、脐带血、白磷、经血、血浆和血清、血小板、红细胞、全血等多种样本类型,满足不同研究方向的需求。
● 生物体液(其他):拥有即装即用的库存,包含各种正常的人类和动物生物体液,如胃肠道生物体液、脂肪抽吸液、眼部生物体液、生殖生物体液、呼吸生物液、唾液、Transcellular Fluid、尿等,提供便捷的研究资源。
● 细胞产品:涵盖脂肪细胞、BMMC、细胞提取物、条件介质、解离的肿瘤细胞、内皮细胞、Epithelial Cells、成纤维细胞、HEPATOMUNE培养物、HEPATOPAC培养物、肝细胞、永生化癌细胞系等众多类型,还包含角质形成细胞、黑色素细胞、Musculoskeletal Cells、非实质细胞、眼细胞、PBMC、周细胞、前细胞、纯化免疫细胞亚群、肾细胞、呼吸细胞、皮肤细胞、干细胞、组织来源的免疫细胞、运输产品等,满足不同研究方向需求。
● 外泌体:来源多样:包括血液外泌体(人)、Mesenchymal Stem Cells(人)、人脐带血血清外泌体、人胎盘来源的外泌体、人前细胞外泌体等。提供外泌体批次的广泛表征分析,包括大小和数量测定、表面蛋白表达、miRNA表达与测序、用于蛋白质组学和脂质组学的LS/MS、电子显微镜观察、稳定性测试、特定目标蛋白质的蛋白质印迹以及多种功能测定。
● 培养基/试剂/试剂盒:养提供培养基、血清和即用型试剂盒,满足细胞培养需求。提供ADME培养基/试剂,用于孵育、解冻和接种肝细胞培养,确保实验最佳条件。提供化学药品,包含高质量化学品,如对照细胞色素P450(CYP)底物及其相应的代谢物,用于早期药物发现服务,帮助加快候选药物选择。
● 分子产物:总RNA、总核酸 - 糖尿病、总RNA - 代谢等产品,为基因表达分析、疾病机制研究等提供了高质量的原料。这些核酸产物经过严格的质量控制,确保其纯度和完整性,满足各种分子生物学实验的需求。
● 亚细胞组分和重组酶:包括匀浆、微粒体、S9、胞浆、非CYP重组酶、细胞等。这些亚细胞组分经过精细的分离和纯化工艺,保留了其原有的生物活性和功能。
● 组织:人体组织及动物组织
①人体组织:其ASTERAND®人体组织标本涵盖了皮肤、软组织、、泌尿系统、中枢神经系统、内分泌腺、胃肠、头颈部、肝、淋巴、乳房、肌肉骨骼、生殖、呼吸等多个系统和器官的组织。这些组织标本经过严格的收集和处理流程,确保其质量和可靠性。
②动物组织:提供来自任何市售动物研究模型的动物组织,如大脑、肾脏、肺、肠道、心脏和皮肤等组织类型的定制制剂,为动物模型研究提供了丰富的资源。
▍Cypex部分产品列表
| 品名 | 货号 | 描述 |
| Human Bone Marrow Aspirate | BOV00BMAK2MP | Bovine Bone Marrow Aspirate K2EDTA Pooled Male |
| Human Bone Marrow Aspirate | HUMANBMANH-0043290 | Human Bone Marrow Aspirate NaHep Normal Frozen, 1mL |
| Human Bone Marrow Aspirate | CUSTOMCELL | Human Bone Marrow Aspirate |
| Non-Human Primate Bone Marrow Aspirate | NHP01BMAK2-0115680 | Cynomolgus Monkey Bone Marrow Aspirate K2EDTA Gender Pooled |
| Non-Human Primate Bone Marrow Aspirate | NHP01BMAK2-0105114 | Cynomolgus Monkey Bone Marrow Aspirate K2EDTA Gender Unspecified |
| Non-Human Primate Bone Marrow Aspirate | NHP01BMAK2-0105116 | Cynomolgus Monkey Bone Marrow Aspirate K2EDTA Gender Unspecified Pooled |
| Non-Human Primate Bone Marrow Aspirate | NHP01BMAK2-0116317 | Cynomolgus Monkey Bone Marrow Aspirate K2EDTA Male |
| Non-Human Primate Bone Marrow Aspirate | NHP01BMAK2-0109008 | Cynomolgus Monkey Bone Marrow Aspirate K2EDTA Male Pooled |
| Non-Human Primate Bone Marrow Aspirate | NHP02BMAK2-0121295 | Rhesus Monkey Bone Marrow Aspirate K2EDTA Gender Unspecified Pooled |
| Non-Human Primate Bone Marrow Aspirate | NHP02BMAK2-0126229 | Rhesus Monkey Bone Marrow Aspirate K2EDTA Male |
| Non-Human Primate Bone Marrow Aspirate | CUSTOMBIOF | Non-Human Primate Bone Marrow Aspirate |
| Mouse Bone Marrow Aspirate | MSE02BMANHP | BALB/C Mouse Bone Marrow Aspirate NaHep Gender Pooled |
| Mouse Bone Marrow Aspirate | MSE01BMANHP | C57BL/6 Mouse Bone Marrow Aspirate NaHep Gender Pooled |
| Mouse Bone Marrow Aspirate | MSE00BMANHP | CD-1 (ICR) Mouse Bone Marrow Aspirate NaHep Gender Pooled |
| Mouse Bone Marrow Aspirate | CUSTOMCELL | Mouse Bone Marrow Aspirate |
| Human Heme-Oncology Bone Marrow | CUSTOMBIOFBLDDS | Human Heme-Oncology Bone Marrow |
| Normal Human Buffy Coat | CUSTOMCELL | Normal Human Buffy Coat |
| Human Cord Blood | HUMANCBCPD-0119137 | Human Cord Blood CPD Female Not Viral Tested Fresh |
| Human Cord Blood | HUMANCBCPD-0119138 | Human Cord Blood CPD Female Viral Negative Fresh |
| Human Cord Blood | HUMANCBPCPD-0129988 | Human Cord Blood Plasma CPD Gender Unspecified, 10mL Frozen |
| Human Cord Blood | HUMANCBS-0129990 | Human Cord Blood Serum Gender Unspecified |
| Human Cord Blood | HUMANCBS-0129989 | Human Cord Blood Serum Gender Unspecified, 1mL Frozen |
| Normal Human GMP VivoSTART™ Leukopak | HUMANGLMX100-0117880 | Human GMP VivoSTART Full Pak Gender Unspecified Cryopreserved |
| Normal Human GMP VivoSTART™ Leukopak | HUMANGLMX100-0109051 | Human GMP VivoSTART Full Pak Gender Unspecified Fresh |
| Normal Human GMP VivoSTART™ Leukopak | HUMANGLMX50-0131914 | Human GMP VivoSTART Half Pak Gender Unspecified Cryopreserved |
| Normal Human GMP VivoSTART™ Leukopak | HUMANGLMX25-0131912 | Human GMP VivoSTART Qtr Pak Gender Unspecified Cryopreserved |
| Normal Human GMP VivoSTART™ Leukopak | HUMANGLMX15B-0131909 | Human GMP VivoSTART XL Gender Unspecified Cryopreserved |
| Normal Human GMP VivoSTART™ Leukopak | HUMANGLMX15B-0131908 | Human GMP VivoSTART XL Gender Unspecified Fresh |

艾美捷科技代理Gene Bridges品牌。
Gene Bridges是一家专注于基因工程和分子克隆技术的公司,提供创新的基因组编辑工具和解决方案,支持基础研究、生物技术和药物开发。Gene Bridges公司采用 Red/ET 重组技术,实现高效、精确的基因组编辑;提供灵活的定制基因组编辑和分子克隆服务,满足客户需求。Gene Bridges公司产品用于基因功能研究、基因组学和分子生物学研究;生物制药、基因治疗和合成生物学;药物靶点验证、基因敲除模型构建和药物筛选;用于作物改良、基因编辑和转基因研究。
其主要产品与服务:
(1)Red/ET 重组技术:提供基于 Red/ET 重组技术的基因工程工具,用于高效、精确的基因组编辑。
(2)分子克隆试剂盒:提供多种分子克隆试剂盒,包括 DNA 片段克隆、基因敲除和基因插入试剂盒。
(3)定制基因组编辑服务:根据客户需求,提供定制化的基因组编辑和分子克隆服务。
(4)技术咨询与支持:提供基因工程和分子克隆相关的咨询和技术支持服务。

艾美捷科技代理InSCREENeX品牌全系列产品
InSCREENeX GmbH成立于2009年,位于德国布伦瑞克亥姆霍兹感染研究中心内,是一家专注于开发细胞筛选技术的德国生物技术公司,InSCREENeX生产用于药物开发的细胞系统。InSCREENeX在该领域拥有超过15年的哺乳动物细胞基因修饰专业知识,在此期间成功开发了SCREENflex和CI-SCREEN这两项高度创新的技术。
利用SCREENflex技术,可以根据客户需求创建稳定的重组哺乳动物细胞。这种方法具有以下优势:快速建立所需的测试系统、目标基因的稳定表达,以及能够以不同水平调控该基因的表达。SCREENflex 技术具有普适性,已成功应用于建立多种蛋白质类别,例如 GPCRs(G蛋白偶联受体)、离子通道、抗体和细胞因子。InSCREENeX公司的产品包括稳定表达细胞系、永生化细胞系以及细胞培养试剂。

▍InSCREENeX产品线
● 稳定表达细胞系:包括离子通道、GPCRs、整合素及其他受体的稳定过表达细胞系
| 品名 | 货号 | Target | Cell background |
| CHO-Nav1.8 | INS-SF-1003 | human Nav1.8 plus beta subunit 1 | CHO |
| CHO-Nav1.7 | INS-SF-1037 | human Nav1.7 | CHO |
| CHO-PD-L1 | INS-SF-1028 | human PD-L1 | CHO |
| CHO-EpCAM | INS-SF-1027 | human EpCAM | CHO |
| CHO-PDCD1 | INS-SF-1026 | human PDCD1 | CHO |
| CHO-BCMA | INS-SF-1025 | human BCMA | CHO |
| CHO-B7H3 | INS-SF-1019 | B7H3 | CHO |
| HEK293-CTLA4 | INS-SF-1014 | CTLA4 | HEK293 |
| CHO-CTLA4 | INS-SF-1013 | CTLA4 | CHO |
| HEK293-CXCR4 | INS-SF-1006 | CXCR4 | HEK293 |
| CHO-CXCR4 | INS-SF-1004-L | CXCR4 | CHO |
| CHO-CXCR4 | INS-SF-1004-MH | CXCR4 | CHO |
| HEK293-CXCR7 | INS-SF-1009 | CXCR7 | HEK293 |
| CHO-CXCR7 | INS-SF-1007-L | CXCR7 | CHO |
| CHO-CXCR7 | INS-SF-1007-MH | CXCR7 | CHO |
| HEK293-FOLR1 | INS-SF-1018 | FOLR1 | HEK293 |
| CHO-FOLR1 | INS-SF-1017 | FOLR1 | CHO |
| HEK293-HER2 | INS-SF-1012 | HER2 | HEK293 |
| CHO-HER2 | INS-SF-1010-MH | HER2 | CHO |
| CHO-HER2 | INS-SF-1010-H | HER2 | CHO |
| HEK293-TACD2 | INS-SF-1016 | TACD2 | HEK293 |
| CHO-TACD2 | INS-SF-1015 | TACD2 | CHO |
| HEK293-FAP | INS-SF-1001 | FAP | HEK293 |
| HEK293-CCR8 | INS-SF-1024 | CCR8 | HEK293 |
| CHO-CCR8 | INS-SF-1023 | CCR8 | CHO |
● 永生化细胞系:来自不同物种的功能性永生化细胞系。
| 品名 | 货号 | Species | Organ/Tissue |
| CI-pNaEC | INS-CI-1029 | porcine | Nasal epithel |
| CI-muMEC | INS-CI-1004 | murine | Vascular endothel |
| CI-muHepa | INS-CI-1012 | murine | Liver, hepatocytes |
| CI-muINTEPI | INS-CI-1007 | murine | Intestinal epithel (fetal) |
| CI-muADINTESTI | INS-CI-1018 | murine | Intestinal epithel (adult) |
| CI-huThyrEC | INS-CI-1017 | human | Thyroid epithel |
| CI-huVEC | INS-CI-1002 | human | Endothel, Umbilical vein |
| CI-huOB | INS-CI-1005 | human | Osteoblasts |
| CI-huMEC | INS-CI-1008 | human | Microvascular endothel |
| CI-huFIB | INS-CI-1010 | human | Fibroblasts |
| CI-huEGC | INS-CI-1030 | human | Enteric glial cells (intestine) |
| CI-huBroBEC | INS-CI-1025 | human | Lung, bronchial epithel |
| CI-hAELVi | INS-CI-1015 | human | Lung, Alveoli |
| CI-huArlo | INS-CI-1031 | human | Lung, Alveoli |
● Reagents and Consumables产品
| 分类 | 品名 | 货号 | 规格 |
| Culture Media | CHO Growth Medium A | INS-ME-1039 | 500 ml |
| Culture Media | CHO Growth Medium B | INS-ME-1040 | 500 ml |
| Culture Media | FasTEER Medium | INS-ME-1032-100 | 100 ml |
| Culture Media | HEK293 Growth Medium A | INS-ME-1041 | 500 ml |
| Culture Media | huAEC Medium | INS-ME-1013-100 | 100 ml |
| Culture Media | huAEC Medium | INS-ME-1013-500 | 500 ml |
| Culture Media | huBroBEC Medium | INS-ME-1033 | 500 ml |
| Culture Media | huEGC Medium | INS-ME-1027 | 500 ml |
| Culture Media | huFIB Medium | INS-ME-1001 | 500 ml |
| Culture Media | huMEC Medium | INS-ME-1012 | 500 ml |
| Culture Media | huOB Differentiation Medium | INS-ME-1007 | 100 ml |
| Culture Media | huOB Maintenance Medium | INS-ME-1006 | 500 ml |
| Culture Media | huThyrEC Medium | INS-ME-1017 | 500 ml |
| Culture Media | huVEC Medium | INS-ME-1011 | 500 ml |
| Culture Media | muADINTESTI Medium | INS-ME-1023 | 500 ml |
| Culture Media | muINTEPI Medium | INS-ME-1005 | 500 ml |
| Culture Media | muMEC Medium | INS-ME-1004 | 500 ml |
| Culture Media | pNaEC Medium | INS-ME-1038 | 500 ml |
| Coating Solutions | Coating Solution | INS-SU-1026 | 50ml;100ml;300ml |
| Freezing Media | Cell Freezing Medium | INS-SU-1027 | 30 ml |
▍InSCREENeX提供的服务
● Landing Pad Cells:将目标单拷贝整合到CHO、HEK293 和 Llama主细胞系中,快速生成细胞系并进行变体库整合。
● Random Integration:通过病毒或非病毒方法将目标基因随机整合到任何细胞系中。
● Cell culture services:高度定制化的细胞系服务,包括细胞库构建、细胞存储、制备:细胞沉淀(Pellets)、细胞裂解液(Lysates)、DNA、RNA、培养基优化,原代细胞分离与分选等。
● Assay services:建立并运行检测方法,包含检测方法建立与优化,代运行检测服务等。
● Molecular biology services:包含克隆构建,质粒制备,DNA/RNA分离提取与制备,慢病毒生产等服务。
" data-original="http://bangs.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理InSCREENeX品牌全系列产品"> 艾美捷科技代理InSCREENeX品牌全系列产品
Eurotrol是一家国际化的质控品生产商,主要服务于诊断行业、PT/EQA(室间质评)项目、标准化单位、医院实验室等。其中,对于诊断和PT/EQA,Eurotrol能够提供定制化的产品和服务;对于标准化单位,Eurotrol为国际上具有声望的如ICSH、NIST提供标准品;Eurotrol提供还为医院实验室提供多种多样的即用型校准物、校准服务等。
Eurotrol具体详情,也可以咨询艾美捷科技丁香通商铺:
https://vicbio.biomart.cn/supply/c_281260.htm
CueSee® HbA1c
CueSee® Hyperbaric
CueSee® Hypoxic
CueSee® tHb
CueSee VeriSTAT® LVM
CueSee VeriSTAT® QC
GAS-ISE
GAS-ISE Metabolites
GAS-ISE Metabolites (with BUN)
GAS-ISE Protein
GlucoLin
GlucoTrol®-AQ
GlucoTrol®-NG
Hb 301 Control
Hct Control
Hematocrit Verification Fluids
HemoLin
HemoTrol®
HemoTrol® WB
HemoxiTrol
Homocysteine
ICSH HiCN Standard
Lipids
P
Plasma/Low Hb Control
Urine Chemistry
Vitamin A/E
Vitamin B1/B6
Eurotrol is a niche player in the world quality control market, offering a wide array of options. Our products have been tailored to meet the needs of the diagnostics industry (OEM), PT / EQA programs, standardization bodies, hospital laboratories and point of care sites.
Diagnostics industry and PT / EQA programs
Eurotrol customizes products for many medical device manufacturers as well as PT / EQA providers all over the world, providing a wide variety of products and services and offering unique packaging forms and processes to further enhance those products.
Standardization bodies
Over the years, Eurotrol has manufactured standards for such prestigious organizations as the International Council for Standardization in Hematology (ICSH) and the National Institute of Standards and Technology (NIST).
Hospital laboratories and point of care sites
Whether the need is for daily liquid quality controls or periodic calibration verification, Eurotrol's product lineup consists of ready-to-use products and services for laboratory and point of care instrumentation.
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
< " data-original="http://bangs.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Eurotrol"> Eurotrol
艾美捷科技代理STEMCELL Technologies品牌。
STEMCELL Technologies为世界各地从事干细胞、免疫学、癌症、再生医学和细胞治疗研究的科学家提供高质量的细胞培养基、细胞分离技术、仪器和配套产品。
STEMCELL Technologies特色产品包括:
(1)EasySep™ 总核酸提取试剂盒:磁性总核酸(DNA 和 RNA)提取试剂盒
(2)CellAdhere™ Laminin-521:与 TeSR™ 维持培养基结合用于维持人 ES 和 iPS 细胞的基质
(3)EasySep™ 人骨髓 CD138 阳性选择试剂盒 (IVD):从骨髓中免疫磁性阳性选择人 CD138+ 细胞用于体外诊断 (IVD) 应用的样品
(4)GyneCult™ 输卵管类器官培养基:无血清和性类固醇模块化试剂盒,用于人类输卵管类器官的扩增和分化
< " data-original="http://bangs.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理STEMCELL Technologies品牌"> 艾美捷科技代理STEMCELL Technologies品牌
艾美捷科技代理Schircks Laboratories品牌。
瑞士Schircks Laboratories由B.Schircks博士于1980年创立,主要生产蝶啶及蝶啶类化合物(Pteridines)。至今,Schircks实验室合成了100多种蝶啶类化合物,主要用于科学研究和临床诊断应用。产品包括:
<| 11.180 | 6-(L-1,2,3-Trihydroxybutyl)-pterin [Rhamnopterin] |
| 11.182 | (6R,S)-5,6,7,8-Tetrahydro-L-rhamnopterin dihydrochloride |
| 11.203 | L-Biopterin [L-erythro-Biopterin] |
| 11.206 | 7,8-Dihydro-L-biopterin |
| 11.209 | (6R,S)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride |
| 11.212 | (6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride |
| 11.213 | (6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride |
| 11.215 | (6S)-5,6,7,8-Tetrahydro-L-biopterin sulfate |
| 11.216 | (6S)-5,6,7,8-Tetrahydro-L-biopterin sulfate |
| 11.217 | (6R)-5-Methyl-5,6,7,8-tetrahydro-L-biopterin dihydrochloride |
| 11.218 | D-Biopterin [D-erythro-Biopterin] |
| 11.220 | (6R,S)-5,6,7,8-Tetrahydro-D-biopterin dihydrochloride |
| 11.221 | D-threo-Biopterin [Dictyopterin] |
| 11.223 | (6R,S)-5,6,7,8-Tetrahydro-D-threo-biopterin dihydrochloride |
| 11.228 | Deoxysepiapterin |
| 11.229 | 6-((1R,S)-Hydroxypropyl)pterin [(1'R,S)-2'-Deoxybiopterin] |
| 11.231 | 7-Biopterin |
| 11.234 | 7-Tetrahydro-L-biopterin dihydrochloride |
| 11.260 | Oncopterin |
| 11.270 | 4-Hydroxy-6-(L-erythro-1,2-dihydroxy-propyl)-2-(methylthio)pteridine |
| 11.280 | 4-Amino-L-biopterin [2,4-Diamino-6-(L-erythro-1',2'-dihydroxypropyl)pteridine] |
| 11.282 | 4-Amino-(6R,S)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride |
| 11.283 | 4-Amino-(6R)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride |
| 11.303 | D-Neopterin [D-erythro-Neopterin] |
| 11.306 | 7,8-Dihydro-D-neopterin |
| 11.307 | 7,8-Dihydro-D-neopterin-3’-triphosphate (Please refer to our reference 8) |
| 11.309 | (6R,S)-5,6,7,8-Tetrahydro-D-neopterin dihydrochloride |
| 11.314 | D-Neopterin-3’-monophosphate, lithium salt |
| 11.315 | 7,8-Dihydro-D-neopterin-3’-monophosphate, lithium salt |
| 11.320 | 3'-Hydroxy-D-sepiapterin |
| 11.330 | 7-Neopterin |
| 11.340 | L-Monapterin [L-threo-Neopterin] |
| 11.345 | 7,8-Dihydro-L-monapterin |
| 11.346 | (6R,S)-5,6,7,8-Tetrahydro-L-monapterin dihydrochloride |
| 11.349 | D-Monapterin [D-threo-Neopterin] |
| 11.403 | Pterin-6-carboxylic acid |
| 11.409 | Pterin-7-carboxylic acid |
| 11.415 | 6-Formylpterin [Pterin-6-aldehyde] |
| 11.416 | 6-Formyl-7,8-dihydropterin |
| 11.418 | Acetyl-6-formylpterin |
| 11.420 | 6-Hydroxymethylpterin |
| 11.421 | 6-Hydroxymethyl-7,8-dihydropterin hydrochloride |
| 11.422 | 6-Hydroxymethyl-7,8-dihydropterin-diphosphate (Please refer to our reference 8) |
| 11.423 | (6R,S)-6-Hydroxymethyl-5,6,7,8-tetrahydropterin dihydrochloride |
| 11.429 | 6-Hydroxymethylpterin-monophosphate |
| 11.438 | 6-Hydroxymethylpterin-diphosphate, lithium salt |
| 11.480 | 6-Methylpterin |
| 11.481 | 6-Methyl-7,8-dihydropterin hydrochloride |
| 11.483 | (6R,S)-6-Methyl-5,6,7,8-tetrahydropterin dihydrochloride |
| 11.503 | 6,7-Dimethylpterin |
| 11.506 | 6,7-Dimethyl-7,8-dihydropterin monohydrochloride |
| 11.509 | 6,7-Dimethyl-5,6,7,8-tetrahydropterin monohydrochloride |
| 11.703 | Leucopterin |
| 11.713 | Xanthopterin |
| 11.716 | Dihydroxanthopterin |
| 11.723 | Isoxanthopterin |
| 11.903 | Pterin |
| 11.906 | 7,8-Dihydropterin (Please refer to our reference 20) |
| 11.909 | 5,6,7,8-Tetrahydropterin dihydrochloride |
| 13.103 | Lumazine |
| 13.203 | 6-Hydroxylumazine |
| 13.206 | 6-Hydroxy-7,8-dihydrolumazine |
| 13.220 | 7-Hydroxylumazine |
| 16.113 | Pteroic acid |
| 16.123 | N10-(Trifluoroacetyl)pteroic acid |
| 16.140 | 10-Formylpteroic acid |
| 16.203 | Folic acid |
| 16.206 | 7,8-Dihydrofolic acid |
| 16.208 | (6S)-5,6,7,8-Tetrahydrofolic acid trihydrochloride |
| 16.209 | (6R,S)-5,6,7,8-Tetrahydrofolic acid trihydrochloride |
| 16.211 | 10-Methylfolic acid |
| 16.215 | 10-Formylfolic acid |
| 16.217 | 10-Formyl-5,6,7,8-tetrahydrofolic acid (Please refer to our reference 19) |
| 16.220 | (6R,S)-5-Formyl-5,6,7,8-tetrahydrofolic acid, calcium salt |
| 16.222 | (6R)-5-Formyl-5,6,7,8-tetrahydrofolic acid, calcium salt (unnatural calcium folinate) |
| 16.230 | (6R,S)-5,10-Methenyl-5,6,7,8-tetrahydrofolic acid chloride |
| 16.233 | (6R,S)-5-Methyl-5,6-dihydrofolic acid, ammonium salt |
| 16.235 | (6R,S)-5-Methyl-5,6,7,8-tetrahydrofolic acid, calcium salt |
| 16.236 | (6S)-5-Methyl-5,6,7,8-tetrahydrofolic acid, calcium salt |
| 16.243 | (6R,S)-5-Methyl-5,6,7,8-tetrahydropteroyltri-γ-L-glutamic acid trihydrochloride |
| 16.244 | (6R,S)-5-Methyl-5,6,7,8-tetrahydropteroyltetra-γ-L-glutamic acid trihydrochloride |
| 16.252 | Pteroyldi-γ-L-glutamic acid |
| 16.253 | Pteroyltri-γ-L-glutamic acid has been discontinued |
| 16.254 | Pteroyltetra-γ-L-glutamic acid |
| 16.255 | Pteroylpenta-γ-L-glutamic acid has been discontinued |
| 16.266 | Pteroylhexa-γ-L-glutamic acid, ammonium salt |
| 16.267 | Pteroylhepta-γ-L-glutamic acid, ammonium salt |
| 16.280 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroic acid |
| 16.282 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyldi-γ-L-glutamic acid, lithium salt has been discontinued |
| 16.283 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyltri-γ-L-glutamic acid, lithium salt has been discontinued |
| 16.284 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyltetra-γ-L-glutamic acid, lithium salt |
| 16.285 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroylpenta-γ-L-glutamic acid, lithium salt |
| 16.286 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroylhexa-γ-L-glutamic acid, lithium salt |
| 16.330 | Aminopterin [4-Aminofolic acid] |
| 16.403 | 4-Amino-10-methylpteroic acid (APA, DAMPA) |
| 16.411 | Methotrexate [4-Amino-10-methylpteroyl-γ-L-glutamic acid] |
| 16.412 | 4-Amino-10-methylpteroyldi-γ-L-glutamic acid, ammonium salt [Methotrexate diglutamate] |
| 16.413 | 4-Amino-10-methylpteroyltri-γ-L-glutamic acid, ammonium salt [Methotrexate triglutamate] |
| 16.414 | 4-Amino-10-methylpteroyltetra-γ-L-glutamic acid, ammonium salt [Methotrexate tetraglutamate] |
| 16.415 | 4-Amino-10-methylpteroylpenta-γ-L-glutamic acid, ammonium salt [Methotrexate pentaglutamate] |
| 16.416 | 4-Amino-10-methylpteroylhexa-γ-L-glutamic acid, ammonium salt [Methotrexate hexaglutamate] |
| 16.417 | 4-Amino-10-methylpteroylhepta-γ-L-glutamic acid, ammonium salt [Methotrexate heptaglutamate] |
| 16.500 | 7-Hydroxymethotrexate |
| 16.701 | p-Aminobenzoyl-L-glutamic acid |
| 16.702 | p-Aminobenzoyldi-γ-L-glutamic acid, ammonium salt |
| 16.703 | p-Aminobenzoyltri-γ-L-glutamic acid, ammonium salt |
| 16.704 | p-Aminobenzoyltetra-γ-L-glutamic acid, ammonium salt |
| 16.705 | p-Aminobenzoylpenta-γ-L-glutamic acid, ammonium salt |
| 16.706 | p-Aminobenzoylhexa-γ-L-glutamic acid, ammonium salt |
| 16.707 | p-Aminobenzoylhepta-γ-L-glutamic acid, ammonium salt has been discontinued |
| 16.901 | Z-Glu-OtBu |
| 16.902 | Z-Glu2-OtBu3 |
| 16.903 | Z-Glu3-OtBu4 |
| 16.904 | Z-Glu4-OtBu5 |
| 16.905 | Z-Glu5-OtBu6 |
| 16.906 | Z-Glu6-OtBu7 |
| 91.303 | D-(5-15N)-Neopterin |
| 96.203 | (5-15N)-Folic acid |

艾美捷科技代理Ocean Nanotech品牌纳米材料。
Ocean Nanotech, LLC专注于纳米材料、纳米技术及其生物医学应用。Ocean Nanotech公司技术特点在于:采用先进的合成技术,确保纳米材料的高纯度和高稳定性;多功能应用: 纳米材料具有广泛的应用前景,包括生物医学、光学、电子学等领域;定制化服务: 提供灵活的定制纳米材料设计和生产服务,满足客户需求。Ocean Nanotech公司纳米材料应用广泛,包括生物标记、细胞成像、药物传递和癌症治疗;光学传感器、光催化和光学成像;用于电子器件、传感器和导电材料;用于环境监测和污染治理。
Ocean Nanotech公司产品包括:
(1)纳米颗粒:提供多种纳米颗粒,包括金纳米颗粒、银纳米颗粒、量子点等,用于生物医学、光学和电子学应用。
(2)纳米材料试剂盒:提供用于生物标记、细胞成像和药物传递的纳米材料试剂盒。
(3)定制纳米材料:根据客户需求,提供定制化的纳米材料设计和生产服务。
(4)纳米技术咨询服务:提供纳米技术相关的咨询和技术支持服务。

艾美捷科技有限公司代理TriLink Biotechnologies 公司产品,包括:
(1)Nucleotides
http://www.amyjet.com/Index/lists/catid/27/kid/49/p/1.html
(2)Hot-start PCR & RT-PCR products
http://www.amyjet.com/Index/lists/catid/27/kid/49/p/29.html
(3)Sequencing Reagents
http://www.amyjet.com/Index/lists/catid/27/kid/49/p/30.html
(4)Stocked mRNA
http://www.amyjet.com/Index/lists/catid/27/kid/49/p/31.html
TriLink BioTechnologies公司是世界著名的核酸修饰技术领域的领导者,成立于1996年,总部设在San Diego,California。TriLink BioTechnologies致力于高品质核酸修饰产品的研发和生产,提供包括核苷酸、常规及核苷三磷酸特殊修饰的寡核苷酸定制(oligonucleotides),mRNA合成,PCR产品,phosphoramidites和其他小分子在内的众多产品。近二十年来,TriLink BioTechnologies一直是诊断和OEM市场核酸产品供应的行业领导者,产品应用于基因治疗,核苷类化疗,寡核苷酸治疗和诊断领域。此外,TriLink BioTechnologies还可提供特殊核苷酸、m RNA定制,合同研究服务和ISO/ QSR标准的cGMP生产设施。TriLink BioTechnologies完善的产品及研发服务解决方案有助于推动药物发现和生物医学研究。
TriLink BioTechnologies specializes in the synthesis of highly modified nucleic acid constructs for research, diagnostic, and therapeutic applications. Since 1996, TriLink has offered cutting edge products to researchers in the fields of gene therapy, nucleoside chemotherapy, oligonucleotide therapy, next generation sequencing, vaccines, and diagnostics. The company manufactures with industry-leading technology, consistent high quality, and ready access to expert scientific support when needed. TriLink develops and manufactures oligonucleotides, mRNA transcripts, nucleotides, bioconjugation, custom chemistry, solutions for PCR & RT-PCR, and NGS library preparation kits. The oligonucleotide and mRNA solutions offered have enabled significant advancements in the biological sciences.
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://bangs.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="TriLink BioTechnologies"> TriLink BioTechnologies
艾美捷科技代理Polysciences品牌。
Polysciences的产品以其高质量和多样性而著称,特别是在聚乙烯亚胺(Polyethylenimine,PEI)转染试剂方面有着显著的优势。Polysciences公司成立于1961年,主要生产和经营生命科学(胶体金、不含甲醛的甲醇等)、病理学和显镜学微球和粒子、磁珠、各种单体和聚体等产品;作为世界上最大最全的多聚化合物供应商,同时也是世界领先的免疫学、组织化学试剂耗材供应商。
Polysciences特色的PEI转染试剂特点包括:
(1)高效性:PEI转染试剂具有高效的瞬转效率和蛋白产量,广泛应用于基因和细胞治疗产品的开发,包括病毒载体和蛋白质工艺开发、临床试验以及商业化生产。
(2)广泛适用性:适用于多种细胞系,如HEK293、CHO、Sf9等,且转染效率高达80%~90%。
(3)升级产品:如PEI MAX 40K,作为第一代PEI 25K的升级产品,其去乙酰化和盐酸盐形式增强了水溶性,提高了转染效率。
产品应用范围包括:
病毒载体开发:可用于生产和优化病毒载体,将基因修饰的病毒载体导入目标细胞内,从而实现基因转染;
重组蛋白表达:可以将编码目标蛋白的基因高效地转入宿主细胞,从而大量表达所需的重组蛋白;
基因编辑技术:如CRISPR-Cas9系统中,PEI转染试剂用于将相关基因编辑组件送入细胞内;
细胞治疗研究:用于提高细胞的治疗效果和生存率,需要将特定的遗传物质传递到细胞内,以改变细胞的行为或增强其治疗效果。
<<<< " data-original="http://bangs.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Polysciences品牌转染试剂"> 艾美捷科技代理Polysciences品牌转染试剂
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18372041646
传真:18372041646
邮箱:sales@amyjet.com
0.1507